Data as of 1:25pm ET
| +0.0299 / +2.79%|
The 3 analysts offering 12-month price forecasts for StemCells Inc have a median target of 2.50, with a high estimate of 5.00 and a low estimate of 2.25. The median estimate represents a +127.29% increase from the last price of 1.10.
The current consensus among 3 polled investment analysts is to Buy stock in StemCells Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.